These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 10915003

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.
    Kim IJ, Kang HC, Park JH, Ku JL, Lee JS, Kwon HJ, Yoon KA, Heo SC, Yang HY, Cho BY, Kim SY, Oh SK, Youn YK, Park DJ, Lee MS, Lee KW, Park JG.
    Clin Cancer Res; 2002 Feb; 8(2):457-63. PubMed ID: 11839664
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
    Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR, Chen CC, Chang R, Chandrasekharappa SC, Collins FS.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
    [Abstract] [Full Text] [Related]

  • 25. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ.
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [Abstract] [Full Text] [Related]

  • 26. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A.
    Forum (Genova); 1998 Aug; 8(2):146-59. PubMed ID: 9666051
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [Abstract] [Full Text] [Related]

  • 30. [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].
    Wiench M, Kwaśniewski M, Gubała E, Wygoda Z, Pawlaczek A, Oczko M, Jarzab B.
    Wiad Lek; 2001 Feb; 54 Suppl 1():415-21. PubMed ID: 12182058
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
    Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J, Billaud M.
    Proc Natl Acad Sci U S A; 1997 Apr 01; 94(7):3330-5. PubMed ID: 9096393
    [Abstract] [Full Text] [Related]

  • 33. Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1997 Apr 01; 81():125-38. PubMed ID: 9474863
    [Abstract] [Full Text] [Related]

  • 34. Sporadic multiple endocrine neoplasia type 2A.
    Yamashita S.
    Intern Med; 1999 Feb 01; 38(2):80. PubMed ID: 10225659
    [No Abstract] [Full Text] [Related]

  • 35. Oncological implications of RET gene mutations in Hirschsprung's disease.
    Sijmons RH, Hofstra RM, Wijburg FA, Links TP, Zwierstra RP, Vermey A, Aronson DC, Tan-Sindhunata G, Brouwers-Smalbraak GJ, Maas SM, Buys CH.
    Gut; 1998 Oct 01; 43(4):542-7. PubMed ID: 9824583
    [Abstract] [Full Text] [Related]

  • 36. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K.
    J Bone Miner Res; 2002 Nov 01; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [Abstract] [Full Text] [Related]

  • 37. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L.
    Oncogene; 1995 Dec 07; 11(11):2419-27. PubMed ID: 8570194
    [Abstract] [Full Text] [Related]

  • 38. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S, Krohn K, Lamesch P, Müller A, Paschke R.
    Eur J Endocrinol; 2000 Jul 07; 143(1):47-54. PubMed ID: 10870030
    [Abstract] [Full Text] [Related]

  • 39. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
    Scarpelli D, D'Aloiso L, Arturi F, Scillitani A, Presta I, Bisceglia M, Cristofaro C, Russo D, Filetti S.
    J Endocrinol Invest; 2004 Dec 07; 27(11):1015-21. PubMed ID: 15754732
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.